In summary, our study show that low LRP1 IHC expression in malignant colon adenocarcinoma cells is a strong prognosis predicator, especially in metastatic patients, in which it predicts a shorter OS in patients treated by anti-VEGF therapies. This evidence concerns the gene LRP1 and colon adenocarcinoma.